1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow bosutinib: new trials by email Literature Review of bosutinib trials Research Report on bosutinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors Bosutinib - Previously Treated PH + CML | Phase 4 | Terminated | Pfizer | 163 | 2014-11-07 | 2021-12-30 |
Bronchiolitis Obliterans Syndrome (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)
Pfizer (1)
Austria (1) · France (1) · Germany (1) · Italy (1) · Norway (1) · Spain (1) · Sweden (1) · United States (1)
PMID 32572189, PMID 35235189, PMID 38007586, PMID 38484432, PMID 39164407